🇺🇸 HAE — Haemonetics Corporation

Salud Compra
← Volver

Precio actual

119,93 USD

Máx. histórico

139,48

2097 días

Split 2:1 del 03/12/2012

Caída desde máximo

-14,02%

Rango 52 semanas

51,00 – 132,00

Variación hoy

-3,37%

Cierre anterior

124,11

Rango de hoy

116,79 – 123,75

Volumen hoy

799.463

Peor caída histórica

-68,62%

08/02/2021 → 27/01/2022

Aún sin recuperar

Volatilidad anualizada ⓘ

34,99%

Información
Nombre completo
Haemonetics Corporation
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Medical Devices
Empleados
3.009
PER ⓘ
53,07 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
124,50 USD (puede no estar actualizado)
Primera cotización
10/05/1991
Precio actualizado
hace 10 horas
Sobre la empresa

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmapheresis equipment system and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. The company also offers treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, it provides hospital products comprising TEG 6s system, smallest cartridge-based viscoelastic analyzer that provides a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, the company offers Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries;vascular closure products comprise VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen; and transfusion management solutions. It sells its products through direct sales force and independent distributors. The company was founded in 1971 and is headquartered in Boston, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
03/12/2012 2:1
11/01/1993 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/04/2013 41,09 41,22 40,50 40,74 -0,66% 1,75% 204.000
03/04/2013 41,83 41,83 40,99 41,01 -1,89% 2,01% 215.400
02/04/2013 41,69 42,19 41,62 41,80 +0,46% 1,37% 255.100
01/04/2013 41,69 42,20 41,49 41,61 -0,12% 1,70% 401.000
28/03/2013 41,38 41,91 41,26 41,66 +0,94% 1,57% 256.000
27/03/2013 41,02 41,32 40,75 41,27 -0,02% 1,39% 87.900
26/03/2013 40,98 41,45 40,79 41,28 +1,10% 1,61% 141.500
25/03/2013 40,73 41,06 40,53 40,83 +0,07% 1,30% 185.300
22/03/2013 41,11 41,22 40,71 40,80 -0,75% 1,24% 249.000
21/03/2013 41,35 41,71 41,01 41,11 -0,94% 1,69% 195.400
20/03/2013 41,58 41,69 41,36 41,50 +0,36% 0,79% 163.800
19/03/2013 41,35 41,63 41,12 41,35 +0,29% 1,23% 249.400
18/03/2013 41,27 41,40 41,07 41,23 -0,65% 0,80% 297.600
15/03/2013 41,16 41,52 41,06 41,50 +0,39% 1,12% 308.300
14/03/2013 41,16 41,40 41,09 41,34 +0,46% 0,75% 145.400
13/03/2013 40,88 41,34 40,69 41,15 +0,76% 1,59% 180.000
12/03/2013 41,36 41,39 40,76 40,84 -1,38% 1,52% 376.100
11/03/2013 41,55 41,60 41,22 41,41 -0,36% 0,91% 183.500
08/03/2013 41,55 41,58 41,27 41,56 +0,65% 0,75% 204.300
07/03/2013 41,62 41,62 41,02 41,29 -0,55% 1,44% 264.600
06/03/2013 41,70 41,97 41,39 41,52 -0,48% 1,39% 189.300
05/03/2013 41,73 41,95 41,58 41,72 +0,48% 0,89% 234.400
04/03/2013 41,69 41,70 41,09 41,52 -0,46% 1,46% 211.000
01/03/2013 40,99 42,12 40,85 41,71 +1,12% 3,10% 489.900
28/02/2013 40,94 41,51 40,92 41,25 +0,78% 1,44% 306.600
27/02/2013 40,75 41,13 40,65 40,93 +0,37% 1,18% 281.500
26/02/2013 40,80 41,20 40,65 40,78 +0,00% 1,35% 261.300
25/02/2013 41,32 41,60 40,77 40,78 -0,83% 2,01% 221.900
22/02/2013 41,32 41,32 40,94 41,12 -0,02% 0,92% 257.700
21/02/2013 40,84 41,35 40,66 41,13 +0,44% 1,69% 375.900